Skip to main content
GlaxoSmithKline PLC logo

GlaxoSmithKline PLC — Investor Relations & Filings

Ticker · GSK ISIN · GB00BN7SWP63 LEI · 5493000HZTVUYLO1D793 IL Manufacturing
Open in API
Filings indexed 7,016 across all filing types
Latest filing 2026-02-20 Transaction in Own Shar…
Country GB United Kingdom
Listing IL GSK

About GlaxoSmithKline PLC

https://www.gsk.com/en-gb/

GSK plc is a global biopharmaceutical company that unites science, technology, and talent to research, develop, and manufacture medicines and vaccines. The company focuses on preventing and treating disease across four primary therapeutic areas: infectious diseases, HIV, oncology, and immunology/respiratory. Its portfolio consists of specialty medicines and vaccines aimed at addressing significant global health needs. GSK's strategy centers on leveraging its research and development capabilities to deliver new health solutions.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is a formal announcement from GSK plc regarding the purchase of its own shares (share buyback) on the London Stock Exchange and other venues. It provides specific details on the number of shares purchased, price paid, and the resulting treasury share balance. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS).
2026-02-20 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is a formal notification of a transaction involving a Person Discharging Managerial Responsibilities (PDMR), specifically Tony Wood, Chief Scientific Officer at GSK plc. It details the vesting of shares under a deferred investment award programme. This type of disclosure is a standard regulatory requirement for insider/director dealings in the UK market, which falls under the 'Director's Dealing' category.
2026-02-19 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is a formal announcement from GSK plc regarding the purchase of its own shares as part of a share buyback program. It details the date of purchase, the number of shares acquired, the price paid, and the impact on treasury shares and total voting rights. This aligns perfectly with the definition for 'Transaction in Own Shares' (Code: POS).
2026-02-19 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is an official announcement from GSK plc regarding the purchase of its own shares (share buyback) on the London Stock Exchange and other venues. It includes specific details such as the number of shares purchased, price paid, and the resulting treasury share balance. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS).
2026-02-18 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is a formal notification of a transaction by a Person Discharging Managerial Responsibilities (PDMR), specifically Maya Martinez-Davis, President of US at GSK plc. It details the vesting of performance shares and the subsequent sale of shares to cover tax liabilities. This type of disclosure is a standard regulatory requirement for insider/director dealings in the UK market, which falls under the 'Director's Dealing' category.
2026-02-17 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is a regulatory notification detailing the vesting of performance share plan awards and subsequent share sales by Persons Discharging Managerial Responsibilities (PDMRs) at GSK plc. This is a standard disclosure of insider transactions, specifically reporting the acquisition of shares through vesting and the sale of shares to cover tax liabilities. This falls directly under the definition of 'Director's Dealing' (DIRS).
2026-02-17 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.